| Literature DB >> 18625368 |
A David Soleymani1, Noah Scheinfeld, Katherine Vasil, Mark A Bechtel.
Abstract
Basal cell carcinoma (BCC), the most common human malignancy, metastasizes in 0.0028% to 0.5% of cases, usually to the lymph nodes, lungs, bones, and skin. After metastatic spread of BCC, survival averages 1 to 2 years. Chemotherapy, radiotherapy, and surgery are treatment options. We describe metastatic basal cell carcinoma to the skin presenting with unilateral upper extremity edema.Entities:
Mesh：
Year: 2008 PMID： 18625368 DOI： 10.1016/j.jaad.2007.08.041
Source DB: PubMed Journal: J Am Acad Dermatol ISSN： 0190-9622 Impact factor: 11.527